Recent technological advances are allowing scientists to redesign organisms or even build new life forms from scratch. This new developing area of research steps beyond traditional Genetic Modification (GM), to combine science and engineering in what is known as Synthetic Biology.
Technologies such as CRISPR-Cas are already allowing us to apply GM to a wide range of fields, from pest control to human genome editing. But these potential practical applications are huge, such as bioengineered micromachines/microorganisms that can destroy cancer cells, detect toxic chemicals or produce drugs that are otherwise incredibly difficult to obtain from nature.
Is society ready for this new discipline? Where should the limits be set? What are the benefits and the risks of these “by-design” organisms?
Four prominent researchers specialised in Synthetic Biology from different backgrounds will discuss these and other pressing questions in our annual debate organised in association with the Linnean Society.
Date: 19th April 2018, from 5.30pm
Venue: The Linnean Society of London, Burlington House, Piccadilly, London, W1J 0BF, United Kingdom
The event is free and open to all but registration is essential. Seats will be allocated on a first-come, first-served basis.
Stay tuned for further updates!